The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Leqembi gains European approval after CHMP reversal, despite safety concerns tied to brain swelling and bleeding in Alzheimer ...

New research found that older individuals who visited the hospital for cannabis-related reasons could be at a higher risk of ...

European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected the drug last summer ...

A novel monitoring and analysis tool may be a feasible method to detect agitation among those living with dementia.

Memory loss is a potential sign of dementia that occurs in progressive stages. Learn about treating and preventing dementia ...

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

How, then, might herpes zoster vaccination reduce the risk of dementia? The authors propose three mechanisms. The first is that a shingles episode might be treated with medications that increase ...

The study found that people with LDL-C levels below 1.8 mmol/L (70 mg/dL) had an even lower risk of dementia when they were also taking statins, suggesting an added protective effect from the ...

A recent study determined the lifetime risk of developing dementia is double that of previous estimates. But there’s good news here too. Alzheimer's disease is a common cause of dementia.